Eastgate Biotech Corp.
ETBI · OTC
12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,544 | -$1,498 | -$3,719 | -$2,977 |
| Dep. & Amort. | $175 | $112 | $73 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $1 |
| Change in WC | $1,287 | $664 | $1,819 | $1,576 |
| Other Non-Cash | $2,196 | $748 | -$986 | $1,012 |
| Operating Cash Flow | $114 | -$258 | -$1,396 | -$389 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$54 | $0 | -$48 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$54 | $0 | -$48 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $1,549 | $322 |
| Stock Issued | $0 | $0 | $46 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $552 | $701 | $0 | $0 |
| Financing Cash Flow | $552 | $701 | $1,595 | $322 |
| Forex Effect | -$606 | $0 | $0 | $49 |
| Net Chg. in Cash | $6 | -$11 | $151 | -$19 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4 | $16 | -$135 | $19 |
| End Cash | $10 | $4 | $16 | $0 |
| Free Cash Flow | $60 | -$258 | -$1,443 | -$389 |